These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9678101

  • 1. Biochemical aspects of hormonal contraception: effects on bone metabolism.
    Volpe A, Amram A, Cagnacci A, Battaglia C.
    Eur J Contracept Reprod Health Care; 1997 Jun; 2(2):123-6. PubMed ID: 9678101
    [Abstract] [Full Text] [Related]

  • 2. Contraception in older woman.
    Volpe A, Silferi M, Genazzani AD, Genazzani AR.
    Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
    [Abstract] [Full Text] [Related]

  • 3. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.
    Mais V, Fruzzetti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB.
    Contraception; 1993 Nov; 48(5):445-52. PubMed ID: 8275694
    [Abstract] [Full Text] [Related]

  • 4. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 5. Bone loss, contraception and lactation.
    Mehta S.
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):148-56. PubMed ID: 8385847
    [Abstract] [Full Text] [Related]

  • 6. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 7. Ovarian function during low-dose oral contraceptive use.
    Egarter C, Putz M, Strohmer H, Speiser P, Wenzl R, Huber J.
    Contraception; 1995 Jun; 51(6):329-33. PubMed ID: 7554971
    [Abstract] [Full Text] [Related]

  • 8. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 9. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jul; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR.
    Osteoporos Int; 2000 Jul; 11(6):544-8. PubMed ID: 10982172
    [Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
    Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR.
    Menopause; 1999 Jul; 6(1):43-8. PubMed ID: 10100179
    [Abstract] [Full Text] [Related]

  • 12. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 14. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May 11; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral contraceptives containing different progestogens on sodium-lithium countertransport in normal females.
    Adebayo GI, Norris L, Devitt M, Bonnar J, Feely J.
    J Hum Hypertens; 1998 Apr 11; 12(4):235-8. PubMed ID: 9607691
    [Abstract] [Full Text] [Related]

  • 16. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
    Caird LE, Reid-Thomas V, Hannan WJ, Gow S, Glasier AF.
    Clin Endocrinol (Oxf); 1994 Dec 11; 41(6):739-45. PubMed ID: 7889609
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.
    Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, Fruzzetti F, Fioretti P.
    Maturitas; 1994 Aug 11; 19(2):125-31. PubMed ID: 7968645
    [Abstract] [Full Text] [Related]

  • 18. Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up.
    Castelo-Branco C, Martínez de Osaba MJ, Pons F, Vanrell JA.
    Eur J Contracept Reprod Health Care; 1998 Jun 11; 3(2):79-84. PubMed ID: 9710711
    [Abstract] [Full Text] [Related]

  • 19. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
    Nappi C, Di Spiezio Sardo A, Greco E, Tommaselli GA, Giordano E, Guida M.
    Obstet Gynecol; 2005 Jan 11; 105(1):53-60. PubMed ID: 15625142
    [Abstract] [Full Text] [Related]

  • 20. Bone-sparing properties of oral contraceptives.
    DeCherney A.
    Am J Obstet Gynecol; 1996 Jan 11; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.